Analysis of quinolone-resistance in commensal and diarrheagenic escherichia coli isolates from infants in lima, Peru

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 108, Issue 1, 2014, Pages 22-28

  Pons, Maria J ^a   Mosquito, S ^b   Gomesa, C ^a   Del Valle, L J ^c   Ochoa, T J ^b   Ruiz, J ^a  

^a CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^b UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^c UNIVERSITAT POLITÈCNICA DE CATALUNYA   (Spain)

Author keywords

Antibiotic resistance; Children; Commensal; Developing countries; Diarrheogenic escherichia coli; Quinolones

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; NALIDIXIC ACID; NORFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; COMMENSAL ESCHERICHIA COLI; DEVELOPING COUNTRY; DIARRHEA; DIARRHEAGENIC ESCHERICHIA COLI; ENTEROAGGREGATIVE ESCHERICHIA COLI; ENTEROPATHOGENIC ESCHERICHIA COLI; ESCHERICHIA COLI; GENE MUTATION; HUMAN; INFANT; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PERU; PHYLOGENY; POLYMERASE CHAIN REACTION;

ANTIBIOTIC RESISTANCE; CHILDREN; COMMENSAL; DEVELOPING COUNTRIES; DIARRHEOGENIC ESCHERICHIA COLI; QUINOLONES;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CIPROFLOXACIN; DIPEPTIDES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; FECES; FEMALE; HUMANS; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; NALIDIXIC ACID; PERU; PREVALENCE; QUINOLONES;

EID: 84891283976     PISSN: 00359203     EISSN: 18783503     Source Type: Journal    
DOI: 10.1093/trstmh/trt106     Document Type: Article

References (32)

1. Okeke IN, Laxminarayan R, Bhutta ZA et al. Antimicrobial resistance in developing countries. Part I: recent trends and current status. Lancet Infect Dis 2005;5:481-93.
2. Sharma M, Eriksson B, Marrone G et al. Antibiotic prescribing in two private sector hospitals; one teaching and one non-teaching: A cross-sectional study in Ujjain, India. BMC Infect Dis 2012;12:155.
3. Chandy SJ, Thomas K, Antonisamy B et al. Patterns of antibiotic use in the community and challenges of antibiotic surveillance crosssectional study in Vellore, south India. J Antimicrob Chemother 2013;68:229-36.
4. Silveira de Castro M, Pilger D, Cardoso Ferreira MB, Kopittke L. Trends in antimicrobial utilization in a university hospital, 1990-1996. Rev Saüde Pü blica 2002;36:553-8.
5. Garciá C, Horna G, Linares E et al. Antimicrobial drug resistance in Peru. Emerg Infect Dis 2012;18:520-1.
6. Gales AC, Castanheira M, Jones RN, Sander HS. Antimicrobial resistance among Gram-negative bacilli isolated from Latin America: results from SENTRY Antimicrobial Surveillance Program (Latin America, 2008-2010). Diagn Microbiol Infect Dis 2012;73:354-60.
7. Pons MJ, Mosquito S, Ochoa TJ et al. Niveles de resistencia a antimicrobianos, en especial a quinolonas, en cepas de Escherichia coli comensales en niños de la zona periurbana de Lima, Perü. Rev Peru Med Exp Salud Püblica 2012;29:82-6.
8. Hooper DC. Emerging mechanisms of fluoroquinolone resistance. Emerg Infect Dis 2001;7:337-41.
9. Ruiz J, Pons MJ, Gomes C. Transferable mechanisms of quinolone resistance. Int J Antimicrob Agents 2012;40:196-203.
10. Rodrïguez-Martïnez JM, Cano ME, Velasco C et al. Plasmid-mediated quinolone resistance: An update. J Infect Chemother 2011;17: 149-82.
11. Nys S, Okeke IN, Kariuki S et al. Antibiotic resistance of faecal Escherichia coli from healthy volunteers from eight developing countries. J Antimicrob Chemother 2004;54:952-5.
12. Ochoa TJ, Ruiz J, Molina M et al. High frequency of antimicrobial drug resistance of diarrheagenic Escherichia coli in infants in Peru. Am J Trop Med Hyg 2009;81:296-301.
13. Ochoa TJ, Ecker L, Barletta F et al. Age-related susceptibility to infection with diarrheagenic Escherichia coli among infants from periurban areas in Lima, Perü . Clin Infect Dis 2009;49:1694-1702.
14. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Twenty-first Informational Supplement M100-S21.2011. Wayne, PA, USA: CLSI; 2011.
15. Saénz Y, Ruiz J, Zarazaga M et al. Effect of efflux pump inhibitor Phe-Arg-b-naphthylamide on the MIC values of quinolones, tetracycline and chloramphenicol in Escherichia coli isolates of different origin. J Antimicrob Chemother 2002;53:544-5.
16. Vila J, Ruiz J, Goñ i P, Jimenez de Anta MT. Detection of mutations in parC in quinolone-resistant clinical isolates of Escherichia coli. Antimicrob Agents Chemother 1996;40:491-3.
17. Park CH, Robicsek A, Jacoby GA et al. Prevalence in the United States of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme. Antimicrob Agents Chemother 2006;50:3953-5.
18. Cattoir V, Poirel L, Rotimi V et al. Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBLproducing enterobacterial isolates. J Antimicrob Chemother 2007; 60:394-7.
19. Yamane K, Wachino JI, Suzuki S, Arakawa Y. Plasmid-mediated qepA gene among Escherichia coli clinical isolates from Japan. Antimicrob Agents Chemother 2008;52:1564-6.
20. Kim HB, Wang M, Park CH et al. OqxAB encoding a multidrug efflux pump in human clinical isolates of Enterobacteriaceae. Antimicrob Agents Chemother 2009;53:3582-4.
21. Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 2000;45:55-8.
22. Vila J, Marcos MA, Jimenez de Anta MT. A comparative study of different PCR-based DNA fingerprinting techniques for typing of the Acinetobacter calcoaceticus- A. baumannii complex. J Med Microbiol 1996;44:482-9.
23. Murray TS, Baltimore RS. Pediatric uses of fluoroquinolone antibiotics. Pediatr Ann 2007;36:336-42.
24. Ecker L, Ochoa TJ, Vargas M et al. Factors affecting caregivers' use of antibiotics available without a prescription in Peru. Pediatrics 2013;131:e1771-9.
25. Llanos-Zavalaga LF, Mayca J, Contreras C. Caracterïsticas de la prescripciön en los consultorios de medicina del hospital Cayetano Heredia de Lima, Perü . Rev Esp Salud Pü blica 2002;76:207-14.
26. Wirtz VJ, Dreser A, Gonzales R. Trends in antibiotic utilization in eight Latin American countries, 1997-2007. Rev Panam Salud Pü blica. 2010;27:219-25.
27. Ruiz L, Pons MJ, Gomes C et al. High antimicrobial-resistance levels of Escherichia coli isolated from meat of several markets in Lima, Peru. Trop Med Int Health 2013:18(Suppl 1):173.
28. Ruiz J. Mechanisms of resistance to quinolones: Target alterations, decreased accumulation and DNA gyrase protection. J Antimicrob Chemother 2003;51:1109-17.
29. Poirel L, Cattoir V, Nordmann P. Plasmid-mediated quinolone resistance; interactions between human, animal, and environmental ecologies. Front Microbiol 2012;3:24.
30. Ribera A, Ruiz J, Jimenez de Anta MT, Vila J. Effect of an efflux pump inhibitor on the MIC of nalidixic acid for Acinetobacter baumannii and Stenotrophomonas maltophilia clinical isolates. J Antimicrob Chemother 2002;49:697-8.
31. Strahilevitz J, Jacoby GA, Hooper DC, Robicsek A. Plasmid-mediated quinolone resistance: a multifaceted threat. Clin Microbiol Rev 2009;22:664-89.
32. Pons MJ, Gomes C, Ruiz J. QnrVC, a new transferable Qnr-like family. Enferm Infecc Microbiol Clin 2013;31:191-2.